Minimal Disease Monitoring in Pediatric Non-Hodgkin’s Lymphoma: Current Clinical Application and Future Challenges

SIMPLE SUMMARY: Minimal residual disease (MRD) describes the detection of a few remaining malignant cells in blood or bone marrow with molecular methods or flow cytometry. The detection of MRD in patients with leukemia during therapy indicates the risk of relapse. Its use for treatment stratificatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussolin, Lara, Damm-Welk, Christine, Pillon, Marta, Woessmann, Wilhelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071445/
https://www.ncbi.nlm.nih.gov/pubmed/33921029
http://dx.doi.org/10.3390/cancers13081907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071445/
https://www.ncbi.nlm.nih.gov/pubmed/33921029
http://dx.doi.org/10.3390/cancers13081907

Ejemplares similares